- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 3.26M sh |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.13M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.85M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.64M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.83M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.97M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $8.06M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 657.7K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.34M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $768.37K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.52M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.91 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.91 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.02M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.1M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.92M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.12M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $117.03K |
| Revenue | Q1 2025 · Mar 31, 2024 | $117.03K |